| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |